-
1Academic Journal
المؤلفون: Babu Rajendran, N., Mutters, Nico Tom, Marasca, Giuseppe, Conti, Michela, Sifakis, Frangiscos G., Vuong, Cuong, Rodríguez-Baño, Jesús, Tacconelli, Evelina
المساهمون: Universidad de Sevilla. Departamento de Medicina, EFPIA companies, Innovative Medicines Initiative Joint Undertaking from the European Union Seventh Framework Programme
مصطلحات موضوعية: Antimicrobial resistance, Europe, Mandatory, Public health, Reporting, Surveillance
Relation: Clinical Microbiology and Infection, 26 (7), 943 e1-943 e6.; FP7/2007-2013; 115737; https://www.sciencedirect.com/science/article/pii/S1198743X19306202?via%3Dihub; https://idus.us.es/handle//11441/143915
-
2Academic Journal
المؤلفون: Babu Rajendran, N, Arieti, F, Mena-Benítez, CA, Galia, L, Tebon, M, Alvarez, J, Gladstone, BP, Collineau, L, De Angelis, G, Duro, R, Gaze, W, Göpel, S, Kanj, SS, Käsbohrer, A, Limmathurotsakul, D, Lopez de Abechuco, E, Mazzolini, E, Mutters, NT, Pezzani, MD, Presterl, E, Renk, H, Rodríguez-Baño, J, Săndulescu, O, Scali, F, Skov, R, Velavan, TP, Vuong, C, Tacconelli, E
المساهمون: group, EPI-Net One Health consensus working
Relation: https://ora.ox.ac.uk/objects/uuid:7cd58c01-d350-43ce-a860-1d554253805c; https://doi.org/10.1016/j.lanepe.2022.100563
-
3Academic JournalIdentifying quantitative evidence-based parameters to monitor emerging resistance to new antibiotics
المؤلفون: Arieti, F, Garlasco, J, Magrini, E, Tebon, M, Compri, M, Babu Rajendran, N, Pezzani, M D, Tacconelli, E
المصدر: European Journal of Public Health ; volume 33, issue Supplement_2 ; ISSN 1101-1262 1464-360X
-
4Academic Journal
المؤلفون: Babu Rajendran, N., Mutters, N.T., Marasca, G., Conti, M., Sifakis, F., Vuong, C., Voss, A., Baño, J.R., Tacconelli, E.
المساهمون: Innovative Medicines Initiative, European Union Seventh Framework Programme, EFPIA
المصدر: Clinical Microbiology and Infection ; volume 26, issue 7, page 943.e1-943.e6 ; ISSN 1198-743X
-
5Electronic Resource
المؤلفون: Babu Rajendran, N., Arieti, F., Mena-Benitez, C. A., Galia, L., Tebon, M., Alvarez, J., Gladstone, B. P., Collineau, L., De Angelis, Giulia, Duro, R., Gaze, W., Gopel, S., Kanj, S. S., Kasbohrer, A., Limmathurotsakul, D., Lopez de Abechuco, E., Mazzolini, E., Mutters, N. T., Pezzani, M. D., Presterl, E., Renk, H., Rodriguez-Bano, J., Sandulescu, O., Scali, F., Skov, R., Velavan, T. P., Vuong, C., Tacconelli, Evelina, Adegnika, A. A., Avery, L., Bonten, M., Cassini, A., Chauvin, C., Compri, M., Damborg, P., De Greeff, S., Del Toro, M. D., Filter, M., Franklin, A., Gonzalez-Zorn, B., Grave, K., Hocquet, D., Hoelzle, L. E., Kalanxhi, E., Laxminarayan, R., Leibovici, L., Malhotra-Kumar, S., Mendelson, M., Paul, M., Munoz Madero, C., Murri, Rita, Piddock, L. J. V., Ruesen, C., Sanguinetti, Maurizio, Schilling, T., Schrijver, R., Schwaber, M. J., Scudeller, L., Torumkuney, D., Van Boeckel, T., Vanderhaeghen, W., Voss, A., Wozniak, T., De Angelis G. (ORCID:0000-0002-7087-7399), Tacconelli E. (ORCID:0000-0001-8722-5824), Murri R. (ORCID:0000-0003-4263-7854), Sanguinetti M. (ORCID:0000-0002-9780-7059)
مصطلحات الفهرس: Antibiotic policy, Antimicrobial consumption, Antimicrobial resistance, One Health, Surveillance, Settore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA, info:eu-repo/semantics/article
URL:
https://hdl.handle.net/10807/231798
info:eu-repo/semantics/altIdentifier/pmid/36895445
volume:26
issue:N/A
firstpage:100563
lastpage:N/A
issueyear:2023
journal:THE LANCET REGIONAL HEALTH. EUROPE -
6Academic Journal
المؤلفون: Schrijver, R., Stijntjes, M., Rodríguez-Baño, J., Tacconelli, E., Babu Rajendran, N., Voss, A.
المصدر: Clinical Microbiology and Infection ; volume 24, issue 6, page 577-590 ; ISSN 1198-743X
-
7Academic Journal
المؤلفون: Núñez-Núñez, M, Navarro, MD, Gkolia, P, Babu Rajendran, N, Del Toro, MD, Voss, A, Sharland, M, Sifakis, F, Tacconelli, E, Rodríguez-Baño, J, and Members of the EPI-NET group on behalf of COMBACTE-MAGNET Co
وصف الملف: application/pdf
Relation: https://openaccess.sgul.ac.uk/id/eprint/108772/1/e014538.full.pdf; Núñez-Núñez, M; Navarro, MD; Gkolia, P; Babu Rajendran, N; Del Toro, MD; Voss, A; Sharland, M; Sifakis, F; Tacconelli, E; Rodríguez-Baño, J; et al. Núñez-Núñez, M; Navarro, MD; Gkolia, P; Babu Rajendran, N; Del Toro, MD; Voss, A; Sharland, M; Sifakis, F; Tacconelli, E; Rodríguez-Baño, J; and Members of the EPI-NET group on behalf of COMBACTE-MAGNET Co (2017) Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review. BMJ Open, 7 (3). e014538. ISSN 2044-6055 https://doi.org/10.1136/bmjopen-2016-014538 SGUL Authors: Sharland, Michael Roy
-
8Electronic Resource
المؤلفون: Universidad de Sevilla. Departamento de Medicina, EFPIA companies, Innovative Medicines Initiative Joint Undertaking from the European Union Seventh Framework Programme, Babu Rajendran, N., Mutters, Nico Tom, Marasca, Giuseppe, Conti, Michela, Sifakis, Frangiscos G., Vuong, Cuong, Rodríguez Baño, Jesús, Tacconelli, Evelina
مصطلحات الفهرس: Antimicrobial resistance, Europe, Mandatory, Public health, Reporting, Surveillance, info:eu-repo/semantics/article
URL:
https://hdl.handle.net/11441/143915 https://www.sciencedirect.com/science/article/pii/S1198743X19306202?via%3Dihub
Clinical Microbiology and Infection, 26 (7), 943 e1-943 e6.
FP7/2007-2013
115737https://www.sciencedirect.com/science/article/pii/S1198743X19306202?via%3Dihub -
9
المؤلفون: Schrijver, R, Stijntjes, M, Rodríguez-Baño, J, Tacconelli, E, Babu Rajendran, N, Voss, A
مصطلحات موضوعية: Veterinary surveillance, Livestock, Meat, Salmonella, Antimicrobial resistance surveillance, Escherichia coli, Antimicrobial resistance, Campylobacter, MRSA, Methicillin-resistant Staphylococcus aureus
-
10Academic Journal
المؤلفون: Núñez-Núñez, María, Navarro, María Dolores, Gkolia, Panagiota, Babu Rajendran, Nithya, Del Toro, María Dolores, Voss, Andreas, Sharland, Mike, Sifakis, Frangiscos, Tacconelli, Evelina, Rodríguez-Baño, Jesús
المساهمون: EPI-NET group on behalf of COMBACTE-MAGNET Consortium., Núñez-Núñez,M, Navarro, MD, Del Toro, MD, Rodríguez-Baño, J Unit of Infectious Disease, Microbiology, and Preventive Medicine, Institute of Biomedicine of Seville (IBIS)/University Hospital Virgen Macarena-Virgen del Rocío/Spanish National Research Council (CSIC), Seville, Spain. Departamento de Medicina, Universidad de Sevilla, Seville, Spain. Núñez-Núñez, M Department of Pharmacy, University Hospital Virgen Macarena, Seville, Spain. Gkolia, P, Babu Rajendran, N, Tacconelli, E Infectious Diseases, Internal Medicine 1, DZIF Center, Tuebingen University Hospital, Tuebingen, Germany. Voss, A Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands. Sharland, M Paediatric Infectious Diseases Research Group, St George's University London, London, UK. Sifakis, F AstraZeneca LP, Gaithersburg, Maryland, USA., Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115737 resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007/2013) and EFPIA companies in kind contribution. JRB also received funding for research from Ministerio de Economía y Competitividad, Instituto de Salud Carlos III—cofinanced by European Development Regional Fund ‘A way to achieve Europe’ ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015).
مصطلحات موضوعية: Bacterias, Infección Hospitalaria, Europa (Continente), Salud pública, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents, Medical Subject Headings::Organisms::Bacteria, Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Cross Infection, Medical Subject Headings::Geographical Locations::Geographic Locations::Europe, Medical Subject Headings::Information Science::Information Science::Communication::Language, Medical Subject Headings::Health Care::Population Characteristics::Health::Public Health, Medical Subject Headings::Information Science::Information Science::Communications Media::Publications, Medical Subject Headings::Health Care::Health Care Economics and Organizations::Organizations::Societies::Societies, Scientific
وصف الملف: application/pdf
Relation: http://bmjopen.bmj.com/content/7/3/e014538.long; Núñez-Núñez M, Navarro MD, Gkolia P, Babu Rajendran N, Del Toro MD, Voss A, et al. Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review. BMJ Open. 2017 Mar 27;7(3):e014538.; http://hdl.handle.net/10668/2615; PMC5372144
-
11
المؤلفون: Nithya, Babu Rajendran, Gladstone, Beryl Primrose, Rodriguez-Bano, Jesus, Sifakis, Frangiscos, Voss, Andreas, Carmeli, Yehuda, Burkert, Francesco Robert, Gkolia, Panagiota, Tacconelli, Evelina
المساهمون: [Babu Rajendran,N, Gladstone,BP, Burkert,FR, Gkolia,P, Tacconelli,A] Division of Infectious Diseases, Department of Internal Medicine 1, DZIF Partner Centre, University Hospital Tuebingen, Tuebingen, Germany. [Rodríguez-Baño,J] Department of Infectious Diseases and Clinical Microbiology, Hospital Universitario Virgen Macarena, Servicio Andaluz de Salud, Sevilla, Spain. [Sifakis,F] AstraZeneca, Gaithersburg, Maryland, USA. [Voss,A] Department of Clinical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital. Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands. [Carmeli,Y] National Center for Antibiotic Resistance and Infection Control, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel., This research project receives support from the Innovative Medicines Initiative Joint Undertaking (IMI JU) under grant agreement numbers 115737(COMBACTE-MAGNET) and 115618 (DRIVE-AB), resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. In addition as a special form of the IMI JU grant, FS received a direct financial contribution from AstraZeneca., [Nithya, Babu Rajendran] Univ Hosp Tuebingen, Div Infect Dis, Dept Internal Med 1, DZIF Partner Ctr, Tubingen, Germany, [Gladstone, Beryl Primrose] Univ Hosp Tuebingen, Div Infect Dis, Dept Internal Med 1, DZIF Partner Ctr, Tubingen, Germany, [Burkert, Francesco Robert] Univ Hosp Tuebingen, Div Infect Dis, Dept Internal Med 1, DZIF Partner Ctr, Tubingen, Germany, [Gkolia, Panagiota] Univ Hosp Tuebingen, Div Infect Dis, Dept Internal Med 1, DZIF Partner Ctr, Tubingen, Germany, [Tacconelli, Evelina] Univ Hosp Tuebingen, Div Infect Dis, Dept Internal Med 1, DZIF Partner Ctr, Tubingen, Germany, [Rodriguez-Bano, Jesus] Hosp Univ Virgen Macarena, Dept Infect Dis & Clin Microbiol, Serv Andaluz Salud, Seville, Spain, [Sifakis, Frangiscos] AstraZeneca, Gaithersburg, MD USA, [Voss, Andreas] Canisius Wilhelmina Hosp, Dept Clin Microbiol & Infect Dis, Nijmegen, Netherlands, [Voss, Andreas] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr Nijmegen, Nijmegen, Netherlands, [Carmeli, Yehuda] Tel Aviv Sourasky Med Ctr, Natl Ctr Antibiot Resistance & Infect Control, Tel Aviv, Israel, Innovative Medicines Initiative Joint Undertaking (IMI JU), European Union Seventh Framework Programme (FP7), EFPIA, AstraZeneca, IMI JU grant
مصطلحات موضوعية: Acinetobacter baumannii, Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Cephalosporins::Cephaloridine::Ceftazidime [Medical Subject Headings], Epidemiology, Health Care::Environment and Public Health::Public Health::Disease Outbreaks [Medical Subject Headings], Diseases::Bacterial Infections and Mycoses::Infection::Cross Infection [Medical Subject Headings], Staphylococcus aureus resistente a meticilina, Multidrug-resistance, Ceftazidima, Health Care::Environment and Public Health::Public Health::Public Health Practice::Communicable Disease Control::Infection Control [Medical Subject Headings], Disciplines and Occupations::Health Occupations::Medicine::Public Health [Medical Subject Headings], Brotes de enfermedades, Phenomena and Processes::Microbiological Phenomena::Bacterial Physiological Phenomena::Drug Resistance, Bacterial::beta-Lactam Resistance::Penicillin Resistance::Methicillin Resistance [Medical Subject Headings], Carbapenémicos, Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Moraxellaceae::Acinetobacter::Acinetobacter baumannii [Medical Subject Headings], Infección hospitalaria, antimicrobial resistance, Ciprofloxacino, Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae [Medical Subject Headings], Organisms::Bacteria::Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Rods::Staphylococcaceae::Staphylococcus::Staphylococcus aureus::Methicillin-Resistant Staphylococcus aureus [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Regression Analysis [Medical Subject Headings], Surveillance, outbreak, Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolases::beta-Lactamases [Medical Subject Headings], Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Pseudomonadaceae::Pseudomonas::Pseudomonas aeruginosa [Medical Subject Headings], Geographicals::Geographic Locations::Europe [Medical Subject Headings], Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Quinolines::Quinolones::Fluoroquinolones::Ciprofloxacin [Medical Subject Headings], Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Escherichia::Escherichia coli [Medical Subject Headings], Spectrum beta-lactamases, Gram-negative bacteria, Chemicals and Drugs::Carbohydrates::Glycoconjugates::Glycopeptides::Vancomycin [Medical Subject Headings], Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Klebsiella::Klebsiella pneumoniae [Medical Subject Headings], Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Carbapenems [Medical Subject Headings], Resistencia a la meticilina, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [Medical Subject Headings]
وصف الملف: application/pdf
-
12Review
المؤلفون: Babu Rajendran, Nithya, Gladstone, Beryl Primrose, Rodríguez-Baño, Jesús, Sifakis, Frangiscos, Voss, Andreas, Carmeli, Yehuda, Burkert, Francesco Robert, Gkolia, Panagiota, Tacconelli, Evelina
المساهمون: Babu Rajendran,N, Gladstone,BP, Burkert,FR, Gkolia,P, Tacconelli,A Division of Infectious Diseases, Department of Internal Medicine 1, DZIF Partner Centre, University Hospital Tuebingen, Tuebingen, Germany. Rodríguez-Baño,J Department of Infectious Diseases and Clinical Microbiology, Hospital Universitario Virgen Macarena, Servicio Andaluz de Salud, Sevilla, Spain. Sifakis,F AstraZeneca, Gaithersburg, Maryland, USA. Voss,A Department of Clinical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital. Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands. Carmeli,Y National Center for Antibiotic Resistance and Infection Control, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel., This research project receives support from the Innovative Medicines Initiative Joint Undertaking (IMI JU) under grant agreement numbers 115737(COMBACTE-MAGNET) and 115618 (DRIVE-AB), resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. In addition as a special form of the IMI JU grant, FS received a direct financial contribution from AstraZeneca.
مصطلحات موضوعية: Epidemiology, Acinetobacter baumannii, Carbapenémicos, Ceftazidima, Ciprofloxacino, Infección hospitalaria, Brotes de enfermedades, Resistencia a la meticilina, Staphylococcus aureus resistente a meticilina, Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Moraxellaceae::Acinetobacter::Acinetobacter baumannii, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents, Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Carbapenems, Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Cephalosporins::Cephaloridine::Ceftazidime, Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Quinolines::Quinolones::Fluoroquinolones::Ciprofloxacin, Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Cross Infection, Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks, Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae, Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Escherichia::Escherichia coli, Medical Subject Headings::Geographicals::Geographic Locations::Europe, Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Public Health Practice::Communicable Disease Control::Infection Control, Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Klebsiella::Klebsiella pneumoniae, Medical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Bacterial Physiological Phenomena::Drug Resistance, Bacterial::beta-Lactam Resistance::Penicillin Resistance::Methicillin Resistance, Medical Subject Headings::Organisms::Bacteria::Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Rods::Staphylococcaceae::Staphylococcus::Staphylococcus aureus::Methicillin-Resistant Staphylococcus aureus, Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Pseudomonadaceae::Pseudomonas::Pseudomonas aeruginosa, Medical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Public Health, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Regression Analysis, Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Glycoconjugates::Glycopeptides::Vancomycin
وصف الملف: application/pdf
Relation: http://bmjopen.bmj.com/content/bmjopen/7/1/e013634.full.pdf; Babu Rajendran N, Gladstone BP, Rodríguez-Baño J, Sifakis F, Voss A, Carmeli Y, et al. EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol. BMJ Open. 2017; 7(1):e013634; http://hdl.handle.net/10668/2586; PMC5223682
Full Text Finder